Legato Capital Management’s Inspire Medical Systems INSP Stock Holding History

Legato Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,125	Closed	-$660K	–	594
2024 Q3	$660K	Buy	+3,125	New	+$543K	0.08%	389
2024 Q2	–	Sell	-1,699	Closed	-$365K	–	597
2024 Q1	$365K	Buy	1,699 +614	+57%	+$120K	0.04%	489
2023 Q4	$221K	Buy	+1,085	New	+$176K	0.03%	517
2023 Q3	–	Sell	-4,327	Closed	-$1.4M	–	588
2023 Q2	$1.4M	Buy	4,327 +944	+28%	+$270K	0.19%	171
2023 Q1	$792K	Hold	3,383	–	–	0.14%	243
2022 Q4	$852K	Buy	+3,383	New	+$721K	0.16%	212
2021 Q3	–	Sell	-1,584	Closed	-$306K	–	255
2021 Q2	$306K	Buy	+1,584	New	+$314K	0.04%	322

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legato Capital Management's INSP Position: Q4 2024 in Review

Legato Capital Management sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 3,125 shares — an estimated $660K sold.

Legato Capital Management first reported a position in INSP in Q2 2021 and held it in 7 quarters. The position peaked at $1.4M in Q2 2023. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

Legato Capital Management reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
Legato Capital Management sold 3,125 Inspire Medical Systems shares in Q4 2024, an estimated $660K.
Legato Capital Management first reported a position in Inspire Medical Systems in Q2 2021 and held it in 7 quarters.
Legato Capital Management's Inspire Medical Systems position peaked at $1.4M in Q2 2023.
357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on Legato Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.